BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27655130)

  • 1. Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.
    Clausen TM; Pereira MA; Al Nakouzi N; Oo HZ; Agerbæk MØ; Lee S; Ørum-Madsen MS; Kristensen AR; El-Naggar A; Grandgenett PM; Grem JL; Hollingsworth MA; Holst PJ; Theander T; Sorensen PH; Daugaard M; Salanti A
    Mol Cancer Res; 2016 Dec; 14(12):1288-1299. PubMed ID: 27655130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility.
    Spliid CB; Toledo AG; Sanderson P; Mao Y; Gatto F; Gustavsson T; Choudhary S; Saldanha AL; Vogelsang RP; Gögenur I; Theander TG; Leach FE; Amster IJ; Esko JD; Salanti A; Clausen TM
    J Biol Chem; 2021 Dec; 297(6):101391. PubMed ID: 34762909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
    Seiler R; Oo HZ; Tortora D; Clausen TM; Wang CK; Kumar G; Pereira MA; Ørum-Madsen MS; Agerbæk MØ; Gustavsson T; Nordmaj MA; Rich JR; Lallous N; Fazli L; Lee SS; Douglas J; Todenhöfer T; Esfandnia S; Battsogt D; Babcook JS; Al-Nakouzi N; Crabb SJ; Moskalev I; Kiss B; Davicioni E; Thalmann GN; Rennie PS; Black PC; Salanti A; Daugaard M
    Eur Urol; 2017 Jul; 72(1):142-150. PubMed ID: 28408175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration.
    Agerbaek MØ; Pereira MA; Clausen TM; Pehrson C; Oo HZ; Spliid C; Rich JR; Fung V; Nkrumah F; Neequaye J; Biggar RJ; Reynolds SJ; Tosato G; Pullarkat ST; Ayers LW; Theander TG; Daugaard M; Bhatia K; Nielsen MA; Mbulaiteye SM; Salanti A
    Int J Cancer; 2017 Apr; 140(7):1597-1608. PubMed ID: 27997697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.
    Salanti A; Clausen TM; Agerbæk MØ; Al Nakouzi N; Dahlbäck M; Oo HZ; Lee S; Gustavsson T; Rich JR; Hedberg BJ; Mao Y; Barington L; Pereira MA; LoBello J; Endo M; Fazli L; Soden J; Wang CK; Sander AF; Dagil R; Thrane S; Holst PJ; Meng L; Favero F; Weiss GJ; Nielsen MA; Freeth J; Nielsen TO; Zaia J; Tran NL; Trent J; Babcook JS; Theander TG; Sorensen PH; Daugaard M
    Cancer Cell; 2015 Oct; 28(4):500-514. PubMed ID: 26461094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dissection of placental malaria protein VAR2CSA interaction with a chemo-enzymatically synthesized chondroitin sulfate library.
    Sugiura N; Clausen TM; Shioiri T; Gustavsson T; Watanabe H; Salanti A
    Glycoconj J; 2016 Dec; 33(6):985-994. PubMed ID: 27287227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria Biomimetic for Tumor Targeted Drug Delivery.
    Pihl J; Clausen TM; Zhou J; Krishnan N; Ørum-Madsen MS; Gustavsson T; Dagil R; Daugaard M; Choudhary S; Foged C; Esko JD; Zhang L; Fang RH; Salanti A
    ACS Nano; 2023 Jul; 17(14):13500-13509. PubMed ID: 37435892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and validation of a plasma oncofetal chondroitin sulfated proteoglycan for pan-cancer detection.
    Zhang PF; Wu ZY; Zhang WB; He YQ; Chen K; Wang TM; Li H; Zheng H; Li DH; Yang DW; Zhou T; Deng CM; Liao Y; Xue WQ; Cao LJ; Li XZ; Zhang JB; Dong SQ; Wang F; Zheng MQ; Zhang WL; Mu J; Jia WH
    Nat Commun; 2023 Feb; 14(1):645. PubMed ID: 36746966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine.
    Clausen TM; Kumar G; Ibsen EK; Ørum-Madsen MS; Hurtado-Coll A; Gustavsson T; Agerbæk MØ; Gatto F; Todenhöfer T; Basso U; Knowles MA; Sanchez-Carbayo M; Salanti A; Black PC; Daugaard M
    Cell Death Discov; 2020; 6():65. PubMed ID: 32793395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Membrane-Coated and VAR2CSA Malaria Protein-Functionalized Nanoparticles for Targeted Treatment of Primary and Metastatic Cancer.
    Zhou M; Lai W; Li G; Wang F; Liu W; Liao J; Yang H; Liu Y; Zhang Q; Tang Q; Hu C; Huang J; Zhang R
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25635-25648. PubMed ID: 34038097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting Cancer Using an Oncofetal Glycosaminoglycan-Binding Protein from Malaria Parasites.
    Agerbæk MØ; Bang-Christensen S; Salanti A
    Trends Parasitol; 2019 Mar; 35(3):178-181. PubMed ID: 30551869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1.
    Ayres Pereira M; Mandel Clausen T; Pehrson C; Mao Y; Resende M; Daugaard M; Riis Kristensen A; Spliid C; Mathiesen L; E Knudsen L; Damm P; G Theander T; R Hansson S; A Nielsen M; Salanti A
    PLoS Pathog; 2016 Aug; 12(8):e1005831. PubMed ID: 27556547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner.
    Agerbæk MØ; Bang-Christensen SR; Yang MH; Clausen TM; Pereira MA; Sharma S; Ditlev SB; Nielsen MA; Choudhary S; Gustavsson T; Sorensen PH; Meyer T; Propper D; Shamash J; Theander TG; Aicher A; Daugaard M; Heeschen C; Salanti A
    Nat Commun; 2018 Aug; 9(1):3279. PubMed ID: 30115931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of rVAR2-Based Isolation of Cancer Cells in Blood for Building a Robust Assay for Clinical Detection of Circulating Tumor Cells.
    Sand NT; Petersen TB; Bang-Christensen SR; Ahrens TD; Løppke C; Jørgensen AM; Gustavsson T; Choudhary S; Theander TG; Salanti A; Agerbæk MØ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bispecific T cell-engager targeting oncofetal chondroitin sulfate induces complete tumor regression and protective immune memory in mice.
    Skeltved N; Nordmaj MA; Berendtsen NT; Dagil R; Stormer EMR; Al-Nakouzi N; Jiang K; Aicher A; Heeschen C; Gustavsson T; Choudhary S; Gögenur I; Christensen JP; Theander TG; Daugaard M; Salanti A; Nielsen MA
    J Exp Clin Cancer Res; 2023 Apr; 42(1):106. PubMed ID: 37118819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.
    Bang-Christensen SR; Pedersen RS; Pereira MA; Clausen TM; Løppke C; Sand NT; Ahrens TD; Jørgensen AM; Lim YC; Goksøyr L; Choudhary S; Gustavsson T; Dagil R; Daugaard M; Sander AF; Torp MH; Søgaard M; Theander TG; Østrup O; Lassen U; Hamerlik P; Salanti A; Agerbæk MØ
    Cells; 2019 Aug; 8(9):. PubMed ID: 31466397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
    Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
    Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer.
    Oo HZ; Lohinai Z; Khazamipour N; Lo J; Kumar G; Pihl J; Adomat H; Nabavi N; Behmanesh H; Zhai B; Dagil R; Choudhary S; Gustavsson T; Clausen TM; Esko JD; Allen JW; Thompson MA; Tran NL; Moldvay J; Dome B; Salanti A; Al-Nakouzi N; Weiss GJ; Daugaard M
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion.
    Faassen AE; Schrager JA; Klein DJ; Oegema TR; Couchman JR; McCarthy JB
    J Cell Biol; 1992 Jan; 116(2):521-31. PubMed ID: 1730766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies.
    Khunrae P; Dahlbäck M; Nielsen MA; Andersen G; Ditlev SB; Resende M; Pinto VV; Theander TG; Higgins MK; Salanti A
    J Mol Biol; 2010 Apr; 397(3):826-34. PubMed ID: 20109466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.